LONDON–(BUSINESS WIRE)–#biotech–MMS Holdings, a data-focused contract research organization (CRO), has been named a Great Place to Work-Certified™ organization in the UK. This comes as the number of MMS colleagues based in the UK has doubled in just one year. “We are proud to be certified as a Great Place to Work in the UK,” said … [Read more…]
The new strategic collaboration will include supporting BioInnovation Institute (BII) to source and potentially fund early-stage start-ups and projects, specifically within the field of reproductive medicine This collaboration helps to fill a gap, given that only 1% of healthcare research funding is invested in female-specific conditions beyond oncology1 SAINT-PREX, Switzerland–(BUSINESS WIRE)–#Fertility–Ferring Pharmaceuticals and BioInnovation announce … [Read more…]
PARIS & CHARLOTTE, N.C.–(BUSINESS WIRE)–ORPHELIA Pharma, a French biopharmaceutical company dedicated to the development and marketing of pediatric and orphan medicines, and Tanner Pharma Group, a global provider of integrated specialty access solutions, have signed an exclusive agreement to manage the supply and distribution of Ped-TMZ, also known as KIMOZO® (temozolomide 40 mg/ml, oral suspension), … [Read more…]
– New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation – In the head and neck cancer trial to date, all patients treated with TG4050 have remained disease-free, despite unfavorable systemic immunity and tumor micro-environment before treatment – Transgene … [Read more…]
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, is pleased to announce its participation in two investor conferences in April 2023. CEO Nawal Ouzren will attend, virtually, Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit, held on April 24-25, 2023. … [Read more…]
At the 2023 American Association for Cancer Research Annual Meeting BI 765063, first-in-class SIRPα inhibitor on the SIRPα/CD47 myeloid pathway in advanced solid tumors. OSE-127, monoclonal immunomodulatory antibody targeting the CD127 receptor, the alpha chain of the interleukin-7 receptor (IL-7R) in Acute Lymphoblastic Leukemia. BiCKI®-IL-7, bifunctional therapy targeting PD1 and IL-7 to sustain exhausted T … [Read more…]
MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well as its … [Read more…]
Camera-based technology expected to help prevent automobile accidents TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has developed a technology to detect serious physical conditions experienced by people driving automobiles, such as loss of consciousness, by estimating pulse rate, changes in blood pressure and other biometric data collected with a contactless Driver Monitoring … [Read more…]
BEIJING–(BUSINESS WIRE)–Data of InnoCare’s (HKEX: 09969; SSE: 688428) robust oncology pipelines were presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting. Oral Presentation: ICP-490 is a highly potent and selective IKZF1/3 degrader with robust anti-tumor activities against multiple myeloma and non-Hodgkin’s lymphoma Abstract Number: 3427 In various multiple myeloma (MM) and non-Hodgkin’s … [Read more…]
TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2022 (“Q4 2022”) and year-end 2022 (“Fiscal 2022”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated. FISCAL 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Fiscal 2022 revenue increased by 32% to $69.1 … [Read more…]
